The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Antipsychotic Medication Adherence: Is There a Difference Between Typical and Atypical Agents?
Abstract
OBJECTIVE: Pharmacy refill records were used to compare medication adherence in outpatient veterans receiving typical versus atypical antipsychotic medications. METHOD: Consecutive patients meeting selection criteria and receiving prescriptions for haloperidol (N=57), perphenazine (N=60), risperidone (N=80), olanzapine (N=63), and quetiapine (N=28) over a 3-month period were identified from a computerized database. The hospital policy at the time of this study required failure in trials of at least two typical antipsychotics before initiation of an atypical agent. Patients' adherence with the antipsychotic regimen was calculated by analyzing refill records for up to 12 months. The cumulative mean gap ratio (the number of days when medication was unavailable in relation to the total number of days) and the compliant fill rate (the number of prescription fills indicating adherence in relation to the total number of prescription fills) at 6 and 12 months were calculated. RESULTS: Adherence rates at 6 and 12 months were moderately higher in patients who received atypical antipsychotics than in those who received typical agents. Cumulative mean gap ratios were 23.2% for typical and 14.1% for atypical antipsychotics at 12 months; thus, patients who received typical agents were without medication for an average of 7 days per month, compared with 4 days per month for those who received atypical agents. At 12 months, compliant fill rates were 50.1% for typical and 54.9% for atypical antipsychotics. CONCLUSIONS: Interventions to improve adherence are warranted even for patients who receive atypical antipsychotic medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Risperidone in the treatment of schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.825 · Cited by 1,193
The assessment of refill compliance using pharmacy records: Methods, validity, and applications
Steiner, J. F., & Prochazka, A. V. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00268-5 · Cited by 1,193
Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings
Fenton, W. S., Blyler, C. R., & Heinssen, R. K. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.4.637 · Cited by 957
Cost of Relapse in Schizophrenia
Weiden, P. J., & Olfson, M. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.3.419 · Cited by 666
Quetiapine in Patients With Schizophrenia: A High- and Low-Dose Double-blind Comparison With Placebo
Small, J. G. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830180067009 · Cited by 478
Steiner, J. F., Koepsell, T. D., Fihn, S. D., & Inui, T. S. (1988) · Medical Care · doi:10.1097/00005650-198808000-00007 · Cited by 458
Predicting Medication Noncompliance After Hospital Discharge Among Patients With Schizophrenia
Olfson, M., Mechanic, D., Hansell, S., Boyer, C. A., Walkup, J., & Weiden, P. J. (2000) · Psychiatric Services · doi:10.1176/appi.ps.51.2.216 · Cited by 410
Medication noncompliance and substance abuse among patients with schizophrenia
(1996) · Psychiatric Services · doi:10.1176/ps.47.8.853 · Cited by 330
A two-year prospective study of treatment compliance in patients with schizophrenia
Buchanan, A. (1992) · Psychological Medicine · doi:10.1017/s0033291700038228 · Cited by 284
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.9.1248 · Cited by 280
Buchanan, R. W., Breier, A., Kirkpatrick, B., Ball, P., & Carpenter, W. T. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.751 · Cited by 264
Measuring Adherence to Behavioral and Medical Interventions
Vitolins, M. Z., Rand, C. S., Rapp, S. R., Ribisl, P. M., & Sevick, M. A. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00077-5 · Cited by 243
Lower Incidence of Tardive Dyskinesia with Risperidone Compared with Haloperidol in Older Patients
Jeste, D. V., Lacro, J. P., Bailey, A., Rockwell, E., Harris, M. J., & Caligiuri, M. P. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb01595.x · Cited by 226
Self-citationSMITH, T. E., HULL, J. W., GOODMAN, M., HEDAYAT-HARRIS, A., WILLSON, D. F., ISRAEL, L. M., & MUNICH, R. L. (1999) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199902000-00006 · Cited by 203
An economic evaluation of schizophrenia-1991
Wyatt, R. J., Henter, I., Leary, M. C., & Taylor, E. (1995) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00789054 · Cited by 200
Medication noncompliance in schizophrenia: codification and update.
Young, J. L., Zonana, H. V., & Shepler, L. (1986) · PubMed · Cited by 198
The economic impact of schizophrenia.
Rice, D. P. (1999) · PubMed · Cited by 184
Conventional vs. Newer Antipsychotics in Elderly Patients
Jeste, D. V., Rockwell, E., Harris, M. J., Lohr, J. B., & Lacro, J. (1999) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199902000-00010 · Cited by 182
Self-citationAn overview of side effects caused by typical antipsychotics.
Arana, G. W. (2000) · PubMed · Cited by 147
Compliance with treatment in schizophrenia: a drug intervention program in a developing country
Salleh, M. R., & Yahya, H. M. (1995) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1995.tb09790.x · Cited by 124
The ups and downs of oral lithium dosing.
Kilts, C. D. (1998) · PubMed · Cited by 123
Garavan, J., Browne, S., Gervin, M., Lane, A., Larkin, C., & O’Callaghan, E. (1998) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(98)90063-3 · Cited by 101
Assertive community treatment and medication compliance in the homeless mentally ill
Dixon, L. B., Weiden, P. J., Torres, M., & Lehman, A. F. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.9.1302 · Cited by 98
Medication compliance among the seriously mentally ill in a public mental health system
Nageotte, C., Sullivan, G., Duan, N., & Camp, P. (1997) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00788920 · Cited by 91
Cabeza, I. G., Amador, M. S., Arango, C., & de Chávez, M. G. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00079-1 · Cited by 89
Noncompliance with arthritis drugs: magnitude, correlates, and clinical implications.
Deyo, R. A., Inui, T. S., & Sullivan, B. (1982) · PubMed · Cited by 86
Use of prescription-refill records to assess patient compliance
Hamilton, R. A., & Briceland, L. L. (1992) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/49.7.1691 · Cited by 84
Rosenheck, R. A., Chang, S. S., Choe, Y., Cramer, J. A., Xu, W., Thomas, J. M., Henderson, W. G., & Charney, D. S. (2000) · PubMed · Cited by 83
Agarwal, M., Sharma, V. K., Kishore Kumar, K. V., & Lowe, D. (1998) · International Journal of Social Psychiatry · doi:10.1177/002076409804400202 · Cited by 76
Measuring the Costs of Schizophrenia: Implications for the Post-Institutional Era in the US
Terkelsen, K. G., & Menikoff, A. (1995) · PharmacoEconomics · doi:10.2165/00019053-199508030-00004 · Cited by 75
Medication Continuation and Compliance
Rosenheck, R. A., Chang, S. S., Choe, Y. H., Cramer, J. A., Xu, W., Thomas, J., Henderson, W. G., & Charney, D. S. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0511 · Cited by 73
Pan, P. C., & Tantam, D. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb10304.x · Cited by 60
Compliance With Depot Antipsychotic Medication by Patients Attending Outpatient Clinics
Heyscue, B. E., Levin, G. M., & Merrick, J. P. (1998) · Psychiatric Services · doi:10.1176/ps.49.9.1232 · Cited by 60
Duncan, J., & Rogers, R. (1998) · Journal of Forensic Sciences · doi:10.1520/jfs14375j · Cited by 53
Appropriate reductions in compliance among well-controlled hypertensive patients
Steiner, J. F., Fihn, S. D., Blair, B., & Inui, T. S. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90097-s · Cited by 49
Interactive risk factors for treatment adherence in a chronic psychotic disorders population
Corriss, D. J., Smith, T. E., Hull, J. W., Lim, R., Pratt, S. I., & Romanelli, S. J. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00111-0 · Cited by 47
Cited by
Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1007 · Cited by 1,383
Self-citationRisk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications
Wang, P. S., Schneeweiss, S., Avorn, J., Fischer, M. A., Mogun, H., Solomon, D. H., & Brookhart, M. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052827 · Cited by 959
Correll, C. U., Leucht, S., & Kane, J. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.414 · Cited by 709
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., & Jeste, D. V. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.692 · Cited by 603
Self-citation
Metadata
- Authors
- Dolder, C. R., Lacro, J. P., Dunn, L. B., & Jeste, D. V.
- Venue
- American Journal of Psychiatry
- Published
- 2002-01-01
- Volume
- 159
- Issue
- 1
- Pages
- 103-108
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2031468415
- Cited by
- 386
- References
- 37
- FWCI
- 21.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.